As AstraZeneca-Oxford coronavirus vaccine enters final stage of testing, here's what we know
@WSJ4 years ago
A trial testing whether a single dose of Johnson & Johnson’s vaccine can safely protect people from Covid-19 follows an earlier study that showed promising results. Four experimental coronavirus shots have now entered Phase 3 testing in the U.S. on.wsj.com
@rt.com5 years ago
Head of Russia’s sovereign wealth fund volunteers testing experimental Covid-19 vaccine on himself
@aljazeera.com5 years ago
Coronavirus: Hundreds willing to be infected for vaccine trials
@rt.com4 years ago
Siberian-made EpiVacCorona Covid-19 vaccine creates antibodies in 100% of participants in initial small-scale trial
@rt.com5 years ago
As world's first Covid-19 vaccine Sputnik V, enters third phase trial, elderly scientists successfully test it on themselves
@theconversation.com5 years ago
The vaccine we're testing in Australia is based on a flu shot. Here's how it could work against coronavirus
@WSJ5 years ago
Researchers have started to recruit healthy Seattle-area volunteers to participate in the first clinical trial of an experimental coronavirus vaccine, a faster-than-expected start for the first vaccine readied for testing on.wsj.com
@rt.com4 years ago
Pfizer expands coronavirus vaccine trial to include children as young as 12
@WSJ5 years ago
Novavax is the latest coronavirus-vaccine developer to advance its testing, saying its candidate started a Phase 2 trial in South Africa on.wsj.com
@rt.com5 years ago
US biotech firm Novavax begins Covid-19 vaccine trials on Australian volunteers after getting $388mn from Bill Gates-backed fund
@nytimesworld4 years ago
The vaccine maker Novavax announced Thursday that it will begin testing its coronavirus vaccine in up to 10,000 volunteers in the United Kingdom. The Maryland company said a larger trial in the United States is expected to begin next month. nyti.ms
@forbes.com5 years ago
Coronavirus Vaccine Begins Final Phase Of Testing In The U.S.
@abc.net.au5 years ago
Pfizer, BioNTech fast-tracking US trials for human testing in bid to have coronavirus vaccine ready by end of year
